Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 27, 2018 - Issue 3
Submit an article Journal homepage
798
Views
2
CrossRef citations to date
0
Altmetric
Review

Investigational drugs in development to prevent neuromyelitis optica relapses

Friedemann PaulCharité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin andHumboldt-Universität zu Berlin and Berlin Institute of Health, NeuroCure Clinical Research Center, Berlin, Germany;Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine Charité - Universitätsmedizin Berlin, Berlin, GermanyCorrespondence[email protected]
View further author information
,
Olwen MurphyDepartment of Neurology, Johns Hopkins University, Baltimore, MD, USAView further author information
,
Santiago PardoDepartment of Neurology, Johns Hopkins University, Baltimore, MD, USAView further author information
&
Michael LevyDepartment of Neurology, Johns Hopkins University, Baltimore, MD, USAView further author information
Pages 265-271 | Received 16 Nov 2017, Accepted 16 Feb 2018, Published online: 28 Feb 2018

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ankelien Duchow, Friedemann Paul & Judith Bellmann-Strobl. (2020) Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders. Expert Opinion on Biological Therapy 20:9, pages 1061-1072.
Read now
Ankelien Duchow, Claudia Chien, Friedemann Paul & Judith Bellmann-Strobl. (2020) Emerging drugs for the treatment of neuromyelitis optica. Expert Opinion on Emerging Drugs 25:3, pages 285-297.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.